Stocksigma LogoStocksigma Logo

Solara Active Pharma Sciences Ltd - Financial Result for the Quarter ended 30th Sep'26

■ Revenue: 417 (+33.1% YoY | +9.4% QoQ) ■ EBITDA: 76.8 (+121.2% YoY | +24.0% QoQ) ■ EBITDA Margin (%): 18.4 (+734 bps YoY | +217 bps QoQ) ■ PAT: 28.5 (Loss

Solara Active Pharma Sciences Ltd - Financial Result for the Quarter ended 30th Sep'26

Solara Active Pharma Sciences Ltd · Outcome · 16 Oct 2026, 7:06 pm

Solara Active Pharma Sciences Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Crore) ■ Revenue: 417 (+33.1% YoY | +9.4% QoQ) ■ EBITDA: 76.8 (+121.2% YoY | +24.0% QoQ) ■ EBITDA Margin (%): 18.4 (+734 bps YoY | +217 bps QoQ) ■ PAT: 28.5 (Loss to Profit YoY | +74.5% QoQ) ■ EPS (INR): 5.92 (Loss to Profit YoY | +68.2% QoQ)

Original exchange filing (PDF)

More announcements from Solara Active Pharma Sciences Ltd

All Solara Active Pharma Sciences Ltd announcements